Due to unhealthy air quality, the campus will be closed on August 24th, 2020. All virtual services and classes will continue as normal.
CLPCCD email is currently unavailable for some District and College users. ITS has identified the problem and is working diligently to resolve the issue. We do not have an estimated time of resolution of this matter. We will update you as necessary. Thank you for your patience.
Congratulations Class of 2020! Although the in-person commencement ceremony is being postponed to a later date, you deserve to be honored and celebrated now!
Employee Email: Due to multiple email issues, the deadline for submitting grades has been extended to 11:00 pm Thursday, May 28, 2020. ITS understands the difficult timing of these issues for communicating with students and is working to restore the problem server as quickly as possible. These servers will be replaced over the Summer.
The blood-brain-barrier (BBB) is a special structure in the body that helps to protect the brain from unwanted toxins and germs. Unfortunately, this barrier can also make it extremely difficult for therapeutics to reach their intended target within brain. This requires the modification of the therapeutic drugs to allow them to cross the BBB and enter the brain where they can reach their target and be effective. Testing which chemical modifications act to improve accessibility of therapeutics to the brain can be a long and expensive process. At LLNL, we are using a drug optimization pipeline that combines several experimental techniques with computational methods, making use of some of the fastest supercomputers in the world. This allows us to speed up the process of optimizing therapeutics to cross the BBB.